BioGeneration III Services BV

Gooimeer 2-35
1411DC Naarden
NL
BioGeneration III Services BV
Foundation date
10/11/2006
Sector
#InvestorSubsector
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech companies. The Company has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €250 million ($300 million) of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.
BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit.
Upcoming events
All events-
2206 '23
Translational Research in Crops
Event by: VIB -
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB
Latest news
More news-
SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance
16 hours ago
Read more
-
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
Read more
-
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Read more